Role of Emerging Insulin Technologies in the Initiation and Intensification of Insulin Therapy for Diabetes in Primary Care
- PMID: 26807007
- PMCID: PMC4714724
- DOI: 10.2337/diaclin.34.1.34
Role of Emerging Insulin Technologies in the Initiation and Intensification of Insulin Therapy for Diabetes in Primary Care
Abstract
In Brief This article explores some of the reasons for the delay in insulin initiation in primary care and evaluates new approaches to insulin therapy that may address these barriers and, therefore, improve insulin use by primary care providers.
References
-
- Klein R. Hyperglycemia and microvascular and macrovascular disease in diabetes. Diabetes Care 1995;18:258–268 - PubMed
-
- UK Prospective Diabetes Study Group Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998;352:837–853 - PubMed
-
- Asche CV, Bode B, Busk AK, Nair SR. The economic and clinical benefits of adequate insulin initiation and intensification in people with type 2 diabetes mellitus. Diabetes Obes Metab 2012;14:47–57 - PubMed
-
- American Diabetes Association Standards of medical care in diabetes—2015. Diabetes Care 2015;38(Suppl. 1):S1–S92 - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
